ZIOPHARM, Inc. Announces FDA Acceptance of IND for Oral Palifosfamide
2/6/2012 9:52:18 AM
More...
|
ZIOPHARM, Inc. Granted European Patent Allowance for Palifosfamide
12/7/2011 6:23:44 AM
More...
|
ZIOPHARM, Inc. Oncology Presents New Darinaparsin Preclinical Prostate and Pancreatic Cancer Data at American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer Meeting
11/16/2011 6:08:14 AM
More...
|
ZIOPHARM, Inc. Presents Preclinical Data for Darinaparsin Effect on Hedgehog Signaling Pathway in Prostate Cancer at AACR-NCI-EORTC Meeting
11/14/2011 9:47:06 AM
More...
|
ZIOPHARM, Inc. Reports Third Quarter Financial Results and Highlights
11/4/2011 6:29:29 AM
More...
|
ZIOPHARM, Inc. Presents Promising Preclinical Pediatric Sarcoma Data with Oral and IV Palifosfamide at the 2011 CTOS/MSTS Meeting
10/28/2011 11:17:59 AM
More...
|
ZIOPHARM, Inc. to Present at Upcoming Investor Conferences
9/20/2011 9:14:05 AM
More...
|
ZIOPHARM, Inc. Seeks Lower Cancer Drug Prices
6/2/2011 7:13:32 AM
More...
|
ZIOPHARM, Inc. to Present at the Jefferies and Co. 2011 Global Healthcare Conference
5/31/2011 11:05:54 AM
More...
|
ZIOPHARM, Inc. Reports First Quarter Financial Results and Highlights
5/5/2011 10:20:41 AM
More...
|
|